HB 616 mandates health benefit plans to cover at-home testing kits for certain diseases, including COVID-19 and influenza, as approved by the FDA. Coverage applies to both individual and group health plans, including Medicaid and CHIP, and requires plans to provide at least four tests per enrollee per month. The law would take effect on September 1, 2025, with coverage applying to plans issued or renewed on or after January 1, 2026. This bill seeks to improve healthcare accessibility and early detection through self-administered testing, potentially reducing burdens on healthcare facilities​.